Novel therapeutic agents for the treatment of autoimmune diseases /

Bibliographic Details
Other Authors: Strand, Vibeke, Scott, David L., 1951-, Simon, Lee S.
Format: Book
Language:English
Published: New York : M. Dekker, [1997]
Subjects:
Table of Contents:
  • 1. Introduction
  • The evaluation of biological agents / Vibeke Strand and David L. Scott
  • 2. Cellular targeted therapies
  • Anti-CD5/ricin a chain immunoconjugate therapy in rheumatoid arthritis / John J. Cush
  • Early clinical studies of IL-2 fusion toxin in patients with severe rheumatoid arthritis, recent-onset insulin-dependent diabetes mellitus, and psoriasis / Thasia G. Woodworth and Karen Parker
  • Chimeric anti-CD4 antibody as a potential therapeutic agent for rheumatoid arthritis / Larry W. Moreland and William J. Koopman.
  • CD4 monoclonal antibody therapy in rheumatoid arthritis / F.C. Breedveld
  • The use of CE9.1, a primatized monoclonal anti-CD4, in the treatment of rheumatoid arthritis / David E. Yocum, Alan M. Solinger, and John A. Lipani
  • CAMPATH-1H therapy in autoimmune diseases / Richard A. Watts and John D. Isaacs
  • CAMPATH-1H in rheumatoid arthritis: United States experience / David E. Yocum and Jeffrey M. Johnston
  • 3. Cytokine targeted therapies
  • Interferon-gamma in the treatment of rheumatoid arthritis / Eric M. Veys, Herman Mielants, and Gust Verbruggen.
  • Tumor necrosis factor blockade in rheumatoid arthritis / Michael J. Elliott, Marc Feldmann, and Ravinder N. Maini
  • Engineered human anti-tumor necrosis factor-alpha (TNFα) antibody, CDP571, in rheumatoid arthritis / Ernest H.S. Choy and Gabriel S. Panayi
  • Clinical experience with recombinant human interleukin-1 receptor type I (Rhu IL-1RI) in patients with rheumatoid arthritis / Richard M. Pope ... [et al.]
  • Treatment of rheumatoid arthritis with soluble tumor necrosis factor receptor / Gary R. Margolies, William J. Koopman, and Larry W. Moreland.
  • 4. Adhesion molecule targeted therapies
  • Treatment of rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule-1 / Arthur F. Kavanaugh and Peter E. Lipsky
  • 5. Potential antigen-specific therapies
  • T-cell-receptor peptide therapy for multiple sclerosis / Arthur A. Vandenbark ... [et al.]
  • T-cell-receptor peptide vaccination studies in rheumatoid arthritis / Louis W. Heck, Larry W. Moreland, and William J. Koopman
  • Oral tolerance for the treatment of autoimmune disease / David A. Hafler and Howard L. Weiner
  • Oral tolerance / David E. Trentham.
  • Intravenous immunoglobulin (IVIg) in the treatment of autoimmune diseases / Vibeke Strand and Martin L. Lee
  • 6. Purine and pyrimidine synthesis inhibitors
  • Inhibitors of de novo nucleotide synthesis in the treatment of rheumatoid arthritis / Robert J. Fox and Randall E. Morris
  • Leflunomide: a new immunosuppressive drug / David L. Scott and Vibeke Strand
  • 7. Future directions
  • An assessment of novel agents in the treatment of the rheumatic diseases / Vibeke Strand and Lee S. Simon.